TherapeuticsMD, Inc.

TXMD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $127.1M $131.5M — — — — $126.4K
Accounts Receivable $4.3M $4.5M $3.0M $2.2M $1.7M $714.4K $26.7K
Inventory $1.5M $1.1M $690.2K $1.2M $1.0M $1.6M $588.1K
Total Current Assets $139.6M $139.4M $70.7M $56.2M $59.4M $4.6M $1.2M
Property, Plant & Equipment $437.1K $516.8K $198.6K $63.3K $61.3K $65.7K $26.8K
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) $3.1M $2.4M $1.6M $1.2M $665.6K $239.6K —
Total Assets $143.2M $142.5M $73.7M $59.1M $62.0M $5.9M $1.4M
Liabilities
Accounts Payable $4.1M $7.4M $3.1M $6.3M $2.1M $1.6M $306.5K
Total Current Liabilities $13.3M $15.0M $10.7M $10.7M $7.3M $3.6M $3.2M
Long-Term Debt — — — — — — —
Total Liabilities $13.3M $15.0M $10.7M $10.7M $7.3M $7.4M $3.2M
Stockholders' Equity
Retained Earnings $-386.7M $-309.7M $-219.8M $-134.7M $-80.5M $-52.1M $-17.0M
Total Stockholders' Equity $129.9M $127.5M $63.1M $48.4M $54.7M $-1.4M $-1.7M
← Newer Page 2 of 2 Older →